Generex's New Plan: Spinout, Reverse Stock Split And Continued Focus On Oral Insulin
The firm believes buccal delivery of oral insulin will succeed where inhaled insulins have failed or stalled in development.
The firm believes buccal delivery of oral insulin will succeed where inhaled insulins have failed or stalled in development.